225 related articles for article (PubMed ID: 26452999)
1. Thrombospondin-1 prevents amyloid beta-mediated synaptic pathology in Alzheimer's disease.
Son SM; Nam DW; Cha MY; Kim KH; Byun J; Ryu H; Mook-Jung I
Neurobiol Aging; 2015 Dec; 36(12):3214-3227. PubMed ID: 26452999
[TBL] [Abstract][Full Text] [Related]
2. Thrombospondin-1 secreted by human umbilical cord blood-derived mesenchymal stem cells rescues neurons from synaptic dysfunction in Alzheimer's disease model.
Kim DH; Lim H; Lee D; Choi SJ; Oh W; Yang YS; Oh JS; Hwang HH; Jeon HB
Sci Rep; 2018 Jan; 8(1):354. PubMed ID: 29321508
[TBL] [Abstract][Full Text] [Related]
3. Protective effects of reduced dynamin-related protein 1 against amyloid beta-induced mitochondrial dysfunction and synaptic damage in Alzheimer's disease.
Manczak M; Kandimalla R; Fry D; Sesaki H; Reddy PH
Hum Mol Genet; 2016 Dec; 25(23):5148-5166. PubMed ID: 27677309
[TBL] [Abstract][Full Text] [Related]
4. Amyloid-β inhibits thrombospondin 1 release from cultured astrocytes: effects on synaptic protein expression.
Rama Rao KV; Curtis KM; Johnstone JT; Norenberg MD
J Neuropathol Exp Neurol; 2013 Aug; 72(8):735-44. PubMed ID: 23860027
[TBL] [Abstract][Full Text] [Related]
5. A role for thrombospondin-1 deficits in astrocyte-mediated spine and synaptic pathology in Down's syndrome.
Garcia O; Torres M; Helguera P; Coskun P; Busciglio J
PLoS One; 2010 Dec; 5(12):e14200. PubMed ID: 21152035
[TBL] [Abstract][Full Text] [Related]
6. Drebrin in Alzheimer's Disease.
Ishizuka Y; Hanamura K
Adv Exp Med Biol; 2017; 1006():203-223. PubMed ID: 28865022
[TBL] [Abstract][Full Text] [Related]
7. High glucose-induced defective thrombospondin-1 release from astrocytes via TLR9 activation contributes to the synaptic protein loss.
Zhao Y; Pu D; Sun Y; Chen J; Luo C; Wang M; Zhou J; Lv A; Zhu S; Liao Z; Zhao K; Xiao Q
Exp Cell Res; 2018 Feb; 363(2):171-178. PubMed ID: 29294308
[TBL] [Abstract][Full Text] [Related]
8. Astrocyte Transforming Growth Factor Beta 1 Protects Synapses against Aβ Oligomers in Alzheimer's Disease Model.
Diniz LP; Tortelli V; Matias I; Morgado J; Bérgamo Araujo AP; Melo HM; Seixas da Silva GS; Alves-Leon SV; de Souza JM; Ferreira ST; De Felice FG; Gomes FCA
J Neurosci; 2017 Jul; 37(28):6797-6809. PubMed ID: 28607171
[TBL] [Abstract][Full Text] [Related]
9. Astrocyte-secreted thrombospondin-1 modulates synapse and spine defects in the fragile X mouse model.
Cheng C; Lau SK; Doering LC
Mol Brain; 2016 Aug; 9(1):74. PubMed ID: 27485117
[TBL] [Abstract][Full Text] [Related]
10. Alzheimer's Disease Risk Factor Pyk2 Mediates Amyloid-β-Induced Synaptic Dysfunction and Loss.
Salazar SV; Cox TO; Lee S; Brody AH; Chyung AS; Haas LT; Strittmatter SM
J Neurosci; 2019 Jan; 39(4):758-772. PubMed ID: 30518596
[TBL] [Abstract][Full Text] [Related]
11. New Alzheimer's disease model mouse specialized for analyzing the function and toxicity of intraneuronal Amyloid β oligomers.
Ochiishi T; Kaku M; Kiyosue K; Doi M; Urabe T; Hattori N; Shimura H; Ebihara T
Sci Rep; 2019 Nov; 9(1):17368. PubMed ID: 31757975
[TBL] [Abstract][Full Text] [Related]
12. The inside-out amyloid hypothesis and synapse pathology in Alzheimer's disease.
Gouras GK; Willén K; Faideau M
Neurodegener Dis; 2014; 13(2-3):142-6. PubMed ID: 24080821
[TBL] [Abstract][Full Text] [Related]
13. RPS23RG1 reduces Aβ oligomer-induced synaptic and cognitive deficits.
Yan L; Chen Y; Li W; Huang X; Badie H; Jian F; Huang T; Zhao Y; Cohen SN; Li L; Zhang YW; Luo H; Tu S; Xu H
Sci Rep; 2016 Jan; 6():18668. PubMed ID: 26733416
[TBL] [Abstract][Full Text] [Related]
14. Neuropep-1 ameliorates learning and memory deficits in an Alzheimer's disease mouse model, increases brain-derived neurotrophic factor expression in the brain, and causes reduction of amyloid beta plaques.
Shin MK; Kim HG; Baek SH; Jung WR; Park DI; Park JS; Jo DG; Kim KL
Neurobiol Aging; 2014 May; 35(5):990-1001. PubMed ID: 24268884
[TBL] [Abstract][Full Text] [Related]
15. Clusterin secreted from astrocyte promotes excitatory synaptic transmission and ameliorates Alzheimer's disease neuropathology.
Chen F; Swartzlander DB; Ghosh A; Fryer JD; Wang B; Zheng H
Mol Neurodegener; 2021 Jan; 16(1):5. PubMed ID: 33517893
[TBL] [Abstract][Full Text] [Related]
16. Disease modifying effect of chronic oral treatment with a neurotrophic peptidergic compound in a triple transgenic mouse model of Alzheimer's disease.
Kazim SF; Blanchard J; Dai CL; Tung YC; LaFerla FM; Iqbal IG; Iqbal K
Neurobiol Dis; 2014 Nov; 71():110-30. PubMed ID: 25046994
[TBL] [Abstract][Full Text] [Related]
17. Gain of PITRM1 peptidase in cortical neurons affords protection of mitochondrial and synaptic function in an advanced age mouse model of Alzheimer's disease.
Du F; Yu Q; Yan S; Zhang Z; Vangavaragu JR; Chen D; Yan SF; Yan SS
Aging Cell; 2021 May; 20(5):e13368. PubMed ID: 33951271
[TBL] [Abstract][Full Text] [Related]
18. Effects of corticosterone and amyloid-beta on proteins essential for synaptic function: implications for depression and Alzheimer's disease.
Wuwongse S; Cheng SS; Wong GT; Hung CH; Zhang NQ; Ho YS; Law AC; Chang RC
Biochim Biophys Acta; 2013 Dec; 1832(12):2245-56. PubMed ID: 23928361
[TBL] [Abstract][Full Text] [Related]
19. A Novel Aβ B-Cell Epitope Vaccine (rCV01) for Alzheimer's Disease Improved Synaptic and Cognitive Functions in 3 × Tg-AD Mice.
Yu YZ; Liu S; Wang HC; Shi D; Xu Q; Zhou XW; Sun ZW; Huang PT
J Neuroimmune Pharmacol; 2016 Dec; 11(4):657-668. PubMed ID: 27147259
[TBL] [Abstract][Full Text] [Related]
20. Isoglutaminyl cyclase contributes to CCL2-driven neuroinflammation in Alzheimer's disease.
Hartlage-Rübsamen M; Waniek A; Meissner J; Morawski M; Schilling S; Jäger C; Kleinschmidt M; Cynis H; Kehlen A; Arendt T; Demuth HU; Rossner S
Acta Neuropathol; 2015 Apr; 129(4):565-83. PubMed ID: 25666182
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
